Trevi Therapeutics Inc. Common Stock is a biopharmaceutical company that focuses on the research and development of therapies for neurological disorders. With their innovative approach and strong pipeline, they aim to provide novel treatment options for patients suffering from Parkinson’s disease and other conditions.
